People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,345.50GBp
11 Feb 2016
Change (% chg)

-- (--)
Prev Close
1,345.50p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,048,629
52-wk High
1,645.00p
52-wk Low
1,227.50p

Search Stocks

Troy, Daniel 

Mr. Daniel Troy is Senior Vice President, General Counsel of GlaxoSmithKline PLC., since September 2008. He was previously a Partner at the Washington law firm Sidley Austin LLP, where he represented mainly pharmaceutical companies and trade associations on matters related to the US Food and Drug Administration (FDA) and government regulations. Dan was formerly Chief Counsel for the FDA, where he served as a primary liaison to the White House and the US Department of Health and Human Services. Dan is a graduate from Cornell University’s School of Industrial and Labor Relations, and earned his law degree from Columbia University School of Law.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks